Latest Regulatory News

Recce Pharmaceuticals has reported compelling preclinical results for its inhaled anti-infective RECCE 327, demonstrating potent activity against multidrug-resistant pneumonia bacteria in mice models.

Santa Fe Minerals Limited has agreed to acquire an 80% stake in four promising gold projects in Côte d’Ivoire, backed by a $6 million placement to accelerate exploration. The deal significantly broadens Santa Fe’s presence in a prolific West African gold region.

Santa Fe Minerals has struck a binding deal to acquire an 80% stake in four gold projects in Côte d’Ivoire, backed by a $6 million placement. The acquisition expands its footprint in West Africa’s prolific gold belt, offering a robust pipeline from early-stage prospects to drill-ready targets.

Invictus Energy updates progress on its AMOG joint venture with Al Mansour Holdings, revealing ongoing negotiations for a significant Qatari ownership stake and deferral of a key placement settlement.

Race Oncology has received ethics approval to launch its HARNESS-1 Phase 1a/b trial testing RC220 combined with osimertinib in EGFR-mutated non-small cell lung cancer patients, marking a key step toward addressing resistance to current therapies.

Whitefield Income Limited has successfully completed a $52.9 million placement to wholesale investors, issuing over 40 million new shares amid strong demand. The capital raise leverages the company’s full placement capacity without requiring shareholder approval.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.

Select Harvests Limited reported a robust FY2025 with a 32.4% almond price surge driving a $30.9 million NPAT increase and halving net debt. The company’s strategic investments and operational efficiencies position it well for a positive FY2026 outlook.

Sarytogan Graphite Limited has raised $1.8 million through a placement to fund its Definitive Feasibility Study and advance key project development activities at its strategic graphite deposit in Kazakhstan.

Electro Optic Systems has resolved ASIC's investigation into its 2022 revenue guidance breaches by agreeing to a $4 million penalty, paving the way for renewed focus on growth and governance.

Syntara Limited has successfully completed Phase 1a trials for its topical anti-fibrotic drug SNT-9465, demonstrating dose-dependent target engagement and safety, and is now progressing to an innovative Phase 1b study in hypertrophic scars.

88 Energy Limited updates on its Alaska-based Project Phoenix, announcing a fully funded horizontal well and extended flow test scheduled for Q3 2026, backed by joint venture partner Burgundy Xploration LLC. The project is positioned for first production as early as 2027 amid a resurgence in North Slope activity.